Loss or mutation of the p53 gene and its related pathways, such as those involving TP53INP1 and TP53INP2 or Bcl-2 and caspase proteins, is positively associated with therapeutic resistance in various cancers [80,81,82,83]. Here, BCL2 is linked to cancer.